Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 2/8/2026

Crotalidae Polyvalent Immune Fab Antivenom Dosing and Clinical Use

Initial Dosing Strategy

  • The recommended initial loading dose for an adult patient is 12 vials of Crotalidae Polyvalent Immune Fab (ovine) administered within the first 8 hours after a pit‑viper bite. 1, 2, 3
  • This formulation is preferred because it is associated with fewer acute and delayed hypersensitivity reactions, allows faster preparation, and is safe in individuals with equine‑serum hypersensitivity. 1, 4, 5

Extended Treatment Requirements

  • A total of 18 vials should be kept on hand to cover the entire 24‑hour treatment window if additional dosing becomes necessary. 1, 2, 3, 7
  • Additional vials beyond the initial 12 may be required for progressive local tissue injury (e.g., worsening swelling or necrosis). 8
  • Systemic manifestations such as hypotension, bleeding, or muscle fasciculations also warrant extra antivenom doses. 8

Antivenom Product Considerations

  • The older Crotalidae polyvalent antivenin has been discontinued; when it is still available, the dosing requirement rises to approximately 30 vials for comparable envenomation severity. 1, 2, 6

Institutional Stocking and Preparedness

  • Hospitals located in regions endemic for rattlesnakes, copperheads, or cottonmouths should maintain sufficient antivenom inventory to treat multiple simultaneous bite victims. 1, 2, 4, 9
  • Facilities should conduct a hazard‑vulnerability assessment that accounts for local snake species distribution and historical bite incidence to determine appropriate stock levels. 1, 4, 5

Clinical Management Priorities

  • Emergency medical services (EMS) must be activated immediately for any suspected venomous snakebite. 8
  • Antivenom is the definitive therapy and should not be administered in first‑aid or pre‑hospital settings; it requires hospital‑based administration. 8
  • Do not postpone antivenom administration while awaiting complete laboratory results when clinical signs of envenomation are evident. 8

Common Pitfalls to Avoid

  • Inadequate initial stocking: the 12‑vial recommendation applies to a single patient; multiple victims require proportionally larger supplies. 1, 4, 5, 9

All facts are derived from peer‑reviewed sources cited above.